Own India's Intellectual
Property Economy.
Access institutional-grade royalty streams, patents, music catalogues and other revenue-generating intangible assets through dedicated single-asset LLP structures. Returns are linked to actual cash flows generated by the underlying assets.
Target returns are illustrative and not guaranteed.
Bharat Pharma Royalty LLP
Royalty rights from a commercialized specialty pharmaceutical product sold in India and Southeast Asia.
The LLP owns economic rights to a royalty stream generated from an approved pharmaceutical product with an established commercial track record.
Investors participate in future royalty collections generated by product sales.
The LLP owns royalty rights only. The LLP does not own the patent.
Returns depend on actual cash flows generated by underlying intellectual property assets and royalty streams. Target IRRs are indicative estimates only. Returns are not guaranteed. Investments are subject to revenue, licensing, regulatory, market and asset-performance risks. Investors should review all available disclosures before investing.
Access institutional-grade IP assets
through single-asset LLPs.
Minimum investment ₹10,000 · KYC required.